Nocardia bacteremia is very rare. We report 2 cases of central venous catheter-associated Nocardia bacteremia and review the literature. The limited clinical experience suggests that discontinuing the catheter and embarking on a relatively short course of appropriate antibiotics results in a good outcome.
before her admission grew 11000 colonies of gram-positive branching rods that were subsequently identified as N. asteroides, whereas a peripheral blood culture taken the same day grew only 3 colonies of the organism. The CVC was removed upon admission, and culture of the catheter tip also grew 1100 colonies of N. asteroides. The patient became atebrile with the discontinuation of the CVC and the initiation of oral trimethoprim/sulfamethoxazole (1 doublestrength tablet 3 times a day) and minocycline (100 mg twice a day) treatment to which the Nocardia isolate was susceptible. A computerized tomography (CT) scan of the patient's chest and head and a transthoracic echocardiogram did not show any abnormalities. A new CVC was inserted, and she received 3 more courses of ABVD plus interferon through it without complications. She chose to discontinue trimethoprim/sulfamethoxazole treatment after 4 weeks because of nausea and rash, but she continued minocycline treatment for a total of 2.5 months. Five months after the discontinuation of antibiotics, the patient's Hodgkin's disease was in complete remission, and there were no signs or symptoms of nocardiosis.
Patient 2. A 46-year-old woman with metastatic breast cancer being treated with docetaxel (Taxotere) and trastuzumab (Herceptin) chemotherapy was admitted to the hospital on 20 June 1999. She had a 6-day history of increasing nonneutropenic fever, chills, malaise, and right subclavian CVC site pain that failed to resolve despite an outpatient trial of oral ciprofloxacin and clindamycin. This patient was also an avid gardener, and she participated in a great deal of outdoor activity on the ranch where she lived. Upon admission, a blood culture taken through the CVC 5 days earlier grew gram-positive branching rods that were subsequently identified as N. asteroides, whereas a peripheral blood culture taken the same day was negative. Upon admission, the patient was febrile (37.7ЊC) but not acutely ill. The CVC site showed erythema and minimal purulent discharge. There were no abnormal findings in her lung, heart, or skin, and neurological examinations also found no abnormalities. Admission laboratory values and chest radiographs were within normal limits.
The CVC was removed when the patient was admitted, and culture of the catheter tip subsequently grew 115 colonies of N. asteroides. A culture of the CVC site was negative. The patient defervesced with the discontinuation of the CVC and the initiation of intravenous imipenem (500 mg every 6 h) and amikacin (7.5 mg/kg per day) treatment to which the Nocardia isolate was susceptible. CT scan of the chest, magnetic resonance image of the head, and transthoracic echocardiogram showed no abnormalities. A new central line was inserted, and she received antibiotics through it as an outpatient for a total of 3 months. Three months after the discontinuation of all antibiotics-and de- spite undergoing subsequent radiation and dexamethasone treatment of metastatic cancer to the brainthe patient has no signs or symptoms of nocardiosis. Nocardia bacteremia is a rare entity, and it represents a spillover of the organism to the bloodstream from either a pulmonary or endovascular source [1] . The notion of Nocardia species causing a device-associated infection is not new, as this organism has long been described to cause catheter-associated peritonitis in patients undergoing continuous peritoneal dialysis [3] . In addition, a Nocardia-like organism, Oerskovia xanthineolytica, has been known to cause CVCassociated bacteremia [4] . In addition to the patients we identified, we found only 2 other reported instances of CVCassociated Nocardia bacteremia that had differences in regard to the underlying disease, the Nocardia species involved, and the diagnosis and management of the bacteremia [5, 6] (table 1) . Therefore, despite their rarity, Nocardia species should be included in the differential diagnosis of CVC-associated bacteremias, especially in patients who have a relevant exposure history.
Although clinical experience with CVC-associated Nocardia bacteremia is limited, the good response seen in the 2 patients we studied supports the prompt removal of the infected CVC and shorter course of antinocardial therapy. In view of the known tropism of the Nocardia species to the skin, brain, and lungs and their association with endocarditis [1, 2] , a systemic workup that includes a careful neurologic, cardiovascular, and cutaneous examination as well as a CT scan of the chest and head and a transthoracic echocardiogram should be considered to rule out secondary seeding of the organism. In addition, if there are any signs of thrombophlebitis, a Doppler ultrasound of the blood vessels should also be included in the workup. However, in the absence of a proven "metastatic" focus of infection that would dictate the usual prolonged therapy (6-12 months), CVC-associated Nocardia bacteremia may be managed successfully with discontinuation of the catheter and a 3-month course of antibiotics.
